Fact Sheet: Ncyte® aCardiomyocytes
.png)
User guide: Ncyte® aCardiomyocytes
Scientific poster: Evaluating compound binding and MoA with human iPSC-derived ...
.png)
Scientific poster: Assessing therapeutic's efficacy in a human iPSC-derived model of ...
Scientific poster: Development and characterization of human iPSC-derived 3D ...
Scientific poster: A human iPSC-based platform to screen therapeutics for ALS using ...
Antisense Oligonucleotide in vitro screening assays: 5 key considerations to make ...
User guide: Ncyte® Smooth Muscle Cells
Fact Sheet: Ncyte® Smooth Muscle Cells
Fact Sheet: Ncyte® Astrocytes
Ready-to-use iPSC-based assay to screen ALS therapeutics
Webinar: Human Hematopoietic Stem Cell Manufacturing from iPSCs
Catalyzing the Discovery of New Treatments for Proteinopathies
Mastering Consistency and Quality in iPSC-Derived Cell Manufacturing to Propel ...
Webinar: Transforming Gene Therapy with human in vitro models
Webinar: Beyond Symptom Relief - the Promising Future of NDD Drug Development with ...
Webinar: Alternative preclinical models to revolutionize cardiac and CNS drug ...
.png)
Webinar: Unlocking the secrets of muscular disease using iPSC models
Webinar: Human iPSC added value to the drug discovery pipeline
Webinar: iPSCs in gene therapy: Potent Solutions
Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target ...
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection ...
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ ASGCT 24: The latest updates from Baltimore
Ncardia @ AD/PD 2024: The Latest In Alzheimer’s & Parkinson’s Research
Ncardia's Remarkable Journey in 2023
.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Development of next generation of high-tech equipment for cell culture applications.
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
